A Novel Nanowell Array Sensor for POC Measurement of Stress Hormones
By LabMedica International staff writers Posted on 13 Jul 2021 |

Image: Artist’s depiction of stress molecules in blood being detected electronically inside nanowells (Photo courtesy of Ella Marushchenko)
Researchers have constructed a microchip "nanosensor" to measure stress hormones such as cortisol in a dedicated nanowell array, which does not require molecular labels or washing steps.
Investigators at Rutgers University (New Brunswick, NJ, USA) designed a nanowell device based on two electrode probes, which were integrated within the nanowell structure. The electrodes were stacked vertically above one another to minimize the electrode spacing. The electrodes were separated by a 40-nanometer insulator layer within the nanowells, meaning that the counter electrodes were actually integrated into the nanowell structure. This sensor geometry limited the exposed surface area of the electrodes, and, as a result, the amount of probe antibody molecules inside the nanowells, while also enhancing the sensitivity by focusing the electric field into the nanowells.
This functional geometry permitted rapid and low volume (less than five microliters) sensing through activation of the wells with antibodies and monitoring of real-time binding events. A 28-well plate biochip was built on a glass substrate by sequential deposition, patterning, and etching steps to create a stacked nanowell array sensor with an electrode gap of 40 nanometers. Sensor response for cortisol concentrations between one and 15 micrograms per deciliter in buffer solution was recorded, and a limit of detection of 0.5 micrograms per deciliter was achieved.
The nanowell array sensor was used to analyze 65 serum samples from patients with rheumatoid arthritis, and the results were compared to those obtained from the standard enzyme-linked immunosorbent assay (ELISA). The results confirmed that nanowell array sensors could be a promising platform for point-of-care testing, where real-time, laboratory-quality diagnostic results are essential.
"The use of nanosensors allowed us to detect cortisol molecules directly without the need for any other molecules or particles to act as labels," said first author Dr. Reza Mahmoodi, a postdoctoral researcher at Rutgers University. "Our new sensor produces an accurate and reliable response that allows a continuous readout of cortisol levels for real-time analysis. It has great potential to be adapted to non-invasive cortisol measurement in other fluids such as saliva and urine. The fact that molecular labels are not required eliminates the need for large bulky instruments like optical microscopes and plate readers, making the readout instrumentation something you can measure ultimately in a small pocket-sized box or even fit onto a wristband one day."
The nanowell array sensor was described in the June 30, 2021, online edition of the journal Science Advances.
Related Links:
Rutgers University
Investigators at Rutgers University (New Brunswick, NJ, USA) designed a nanowell device based on two electrode probes, which were integrated within the nanowell structure. The electrodes were stacked vertically above one another to minimize the electrode spacing. The electrodes were separated by a 40-nanometer insulator layer within the nanowells, meaning that the counter electrodes were actually integrated into the nanowell structure. This sensor geometry limited the exposed surface area of the electrodes, and, as a result, the amount of probe antibody molecules inside the nanowells, while also enhancing the sensitivity by focusing the electric field into the nanowells.
This functional geometry permitted rapid and low volume (less than five microliters) sensing through activation of the wells with antibodies and monitoring of real-time binding events. A 28-well plate biochip was built on a glass substrate by sequential deposition, patterning, and etching steps to create a stacked nanowell array sensor with an electrode gap of 40 nanometers. Sensor response for cortisol concentrations between one and 15 micrograms per deciliter in buffer solution was recorded, and a limit of detection of 0.5 micrograms per deciliter was achieved.
The nanowell array sensor was used to analyze 65 serum samples from patients with rheumatoid arthritis, and the results were compared to those obtained from the standard enzyme-linked immunosorbent assay (ELISA). The results confirmed that nanowell array sensors could be a promising platform for point-of-care testing, where real-time, laboratory-quality diagnostic results are essential.
"The use of nanosensors allowed us to detect cortisol molecules directly without the need for any other molecules or particles to act as labels," said first author Dr. Reza Mahmoodi, a postdoctoral researcher at Rutgers University. "Our new sensor produces an accurate and reliable response that allows a continuous readout of cortisol levels for real-time analysis. It has great potential to be adapted to non-invasive cortisol measurement in other fluids such as saliva and urine. The fact that molecular labels are not required eliminates the need for large bulky instruments like optical microscopes and plate readers, making the readout instrumentation something you can measure ultimately in a small pocket-sized box or even fit onto a wristband one day."
The nanowell array sensor was described in the June 30, 2021, online edition of the journal Science Advances.
Related Links:
Rutgers University
Latest Technology News
- Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer
- Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
- Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
- Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
- Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
- Smartphones Could Diagnose Diseases Using Infrared Scans
- Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
- 3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
- POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
- Study Explores Impact of POC Testing on Future of Diagnostics
- Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
- Nanotechnology For Cervical Cancer Diagnosis Could Replace Invasive Pap Smears
- Lab-On-Chip Platform to Expedite Cancer Diagnoses
- Biosensing Platform Simultaneously Detects Vitamin C and SARS-CoV-2
- New Lens Method Analyzes Tears for Early Disease Detection
- FET-Based Sensors Pave Way for Portable Diagnostic Devices Capable of Detecting Multiple Diseases
Channels
Clinical Chemistry
view channelMass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication
Speed and accuracy are essential when diagnosing diseases. Traditionally, diagnosing bacterial infections involves the labor-intensive process of isolating pathogens and cultivating bacterial cultures,... Read more
First Comprehensive Syphilis Test to Definitively Diagnose Active Infection In 10 Minutes
In the United States, syphilis cases have surged by nearly 80% from 2018 to 2023, with 209,253 cases recorded in the most recent year of data. Syphilis, which can be transmitted sexually or from mother... Read more
Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse
Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read moreHematology
view channel
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read more
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Molecular Stool Test Shows Potential for Diagnosing TB in Adults with HIV
Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, led to 1.25 million deaths in 2023, with 13% of those occurring in people living with HIV. The current primary diagnostic method for... Read more
New Test Diagnoses Bacterial Meningitis Quickly and Accurately
Bacterial meningitis is a potentially fatal condition, with one in six patients dying and half of the survivors experiencing lasting symptoms. Therefore, rapid diagnosis and treatment are critical.... Read morePathology
view channel
Groundbreaking Chest Pain Triage Algorithm to Transform Cardiac Care
Cardiovascular disease is responsible for a third of all deaths worldwide, and chest pain is the second most common reason for emergency department (ED) visits. With EDs often being some of the busiest... Read more
AI-Based Liquid Biopsy Approach to Revolutionize Brain Cancer Detection
Detecting brain cancers remains extremely challenging, with many patients only receiving a diagnosis at later stages after symptoms like headaches, seizures, or cognitive issues appear. Late-stage diagnoses... Read moreTechnology
view channel
Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer
Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more